LungVax Trial: UCL Oxford Lead Preventive Lung Cancer Vaccine | AcademicJobs
UCL and Oxford researchers launch Phase I trial for LungVax, the first vaccine to prevent lung cancer by targeting precancerous cells. Explore the science, TRACERx origins, and implications for UK higher education.
immunotherapyresearch-publication-newsuniversity-of-oxford

